Clinical Trial Update: Use of Armodafinil for Fatigue in Sarcoidosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluated armodafinil for fatigue in individuals with sarcoidosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Fatigue | Phase 2, Phase 3 | Status: COMPLETED